当前位置: 首页 >> 检索结果
共有 15411 条符合本次的查询结果, 用时 7.9874489 秒

141. Clopidogrel versus aspirin for coronary artery disease - Authors' reply.

作者: Marco Valgimigli.;Felice Gragnano.;Daniele Giacoppo.
来源: Lancet. 2026年407卷10531期853-854页

142. Clopidogrel versus aspirin for coronary artery disease.

作者: Ahmed Ibrahim.;Laila Shalabi.;Giuseppe Andó.
来源: Lancet. 2026年407卷10531期853页

143. Clopidogrel versus aspirin for coronary artery disease.

作者: Cinzia Dello Russo.;Luigi Venetucci.;Ronnie Ramlogan.;Dimitri Gagliardi.;Abisobe Akintola.;Munir Pirmohamed.
来源: Lancet. 2026年407卷10531期852-853页

144. Clopidogrel versus aspirin for coronary artery disease.

作者: Agostino Colli.;Giovanni Casazza.;Christian Gluud.
来源: Lancet. 2026年407卷10531期851-852页

145. Peace: more than an end to war.

作者: Farhang Tahzib.
来源: Lancet. 2026年407卷10531期851页

146. The role of health-care professionals and stakeholders.

作者: Christos Lionis.
来源: Lancet. 2026年407卷10531期850-851页

147. Watching the watchers: a reply from Global Health Watch 7.

作者: Ronald Labonté.;Chiara Bodini.
来源: Lancet. 2026年407卷10531期849-850页

148. Being human: ableism, advocacy, and strengthening medicine.

作者: Michael J Quon.
来源: Lancet. 2026年407卷10531期844-845页

149. Decoding the language of sleep with artificial intelligence.

作者: James Zou.;Eric J Topol.
来源: Lancet. 2026年407卷10531期843页

150. Maria Antonieta Alcalde Castro: new Director General of IPPF.

作者: Udani Samarasekera.
来源: Lancet. 2026年407卷10531期842页

151. Offline: A new narrative for global health?

作者: Richard Horton.
来源: Lancet. 2026年407卷10531期837页

152. Antipsychotic medicines for schizophrenia: time to move forward.

作者: Corrado Barbui.;Giovanni Ostuzzi.
来源: Lancet. 2026年407卷10531期829-831页

153. First steps of a potential new era in fetal intervention for spina bifida.

作者: Magdalena Sanz Cortes.
来源: Lancet. 2026年407卷10531期827-829页

154. Reassuring survival results of modern hip replacements.

作者: Jonathan Thomas Evans.;Jenna Shepherd.
来源: Lancet. 2026年407卷10531期826-827页

155. Robert F Kennedy Jr: 1 year of failure.

作者: The Lancet.
来源: Lancet. 2026年407卷10531期825页

156. Managing complex antiretroviral regimens.

作者: Michael S Saag.
来源: Lancet. 2026年407卷10535期1211-1213页

157. Switch to single-tablet bictegravir-lenacapavir from a complex HIV regimen (ARTISTRY-1): a randomised, open-label, phase 3 clinical trial.

作者: Chloe Orkin.;Peter J Ruane.;Malcolm Hedgcock.;Cyril Gaultier.;Marcelo H Losso.;Benoit Trottier.;Thomas Lutz.;Mark O'Reilly.;Mark Bloch.;Jihad Slim.;Moti Ramgopal.;Simiso Sokhela.;Karam Mounzer.;Hung-Chin Tsai.;Jorge Santana Bagur.;Xu Zhang.;Keith Aizen.;Kwanza Price.;Nicolas Margot.;Jairo M Montezuma-Rusca.;Peter Sklar.;Martin Rhee.;Pedro Cahn.; .
来源: Lancet. 2026年407卷10535期1249-1258页
Single-tablet regimens (STRs) revolutionised HIV-1 treatment, improving adherence and clinical outcomes; however, many people cannot take these due to resistance, contraindications, or drug-drug interactions, instead relying on complex multi-tablet regimens. Novel STRs are therefore needed. We aimed to evaluate the efficacy and safety of a novel STR, bictegravir-lenacapavir, in people with HIV-1.

158. Fundamental PEPFAR reform risks a period of structural vulnerability in the HIV response.

作者: Jirair Ratevosian.;Chris Beyrer.
来源: Lancet. 2026年407卷10533期1035-1038页

159. Mark Butler: steering Australia's health portfolio.

作者: Tony Kirby.
来源: Lancet. 2026年407卷10533期1045页

160. Student suicide risk and counselling in the Kurdistan Region of Iraq.

作者: Pegah A M Seidi.;Dilshad Jaff.;Zamdar H Rasul Karim.
来源: Lancet. 2026年407卷10531期848-849页
共有 15411 条符合本次的查询结果, 用时 7.9874489 秒